- Report
- March 2024
- 197 Pages
Global
From €3249EUR$3,374USD£2,794GBP
€3610EUR$3,749USD£3,105GBP
- Report
- November 2023
- 148 Pages
Global
From €2407EUR$2,499USD£2,070GBP
- Report
- March 2024
- 175 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- January 2024
- 200 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- January 2024
- 200 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- October 2023
- 181 Pages
Global
From €4719EUR$4,900USD£4,058GBP
- Report
- December 2023
Global
From €7223EUR$7,500USD£6,212GBP
- Report
- April 2023
- 75 Pages
Global
From €3611EUR$3,750USD£3,106GBP
- Report
- August 2022
- 116 Pages
Global
From €4574EUR$4,750USD£3,934GBP
- Report
- April 2022
- 121 Pages
Global
From €4285EUR$4,450USD£3,686GBP
- Report
- September 2023
- 86 Pages
Global
From €3500EUR$3,893USD£3,115GBP
- Report
- May 2023
- 249 Pages
Global
From €5518EUR$5,730USD£4,746GBP
- Report
- May 2023
- 458 Pages
Global
From €5518EUR$5,730USD£4,746GBP
The Blood Clot market is a subset of the Hematology market, which focuses on the diagnosis and treatment of blood-related disorders. Blood clots are a common medical condition that can cause serious health complications, such as stroke, deep vein thrombosis, and pulmonary embolism. Treatment for blood clots typically involves anticoagulants, thrombolytics, and thrombectomy. Anticoagulants are used to prevent the formation of new clots, while thrombolytics are used to dissolve existing clots. Thrombectomy is a surgical procedure used to remove large clots.
The Blood Clot market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Bayer, Pfizer, Sanofi, Bristol-Myers Squibb, and Johnson & Johnson. Other companies in the market include Merck, Novartis, AstraZeneca, and GlaxoSmithKline. Show Less Read more
